PathoNostics
Own or work here?
Contact Listing Owner
Contact Now!
PathoNostics was founded in 2011 in Maastricht in The Netherlands, and is currently on the Brightland Campus. We are a strong, motivated team consisting of employees with a scientific background and experience in the field of mycology.
Our goal is to develop and commercialize real-time PCR assays for the diagnosis of superficial and invasive fungal infections. Our assays advance the diagnosis of fungal infections and allow antifungal therapy to be more appropriately targeted. Three products are currently available: AsperGenius®, DermaGenius®, and PneumoGenius®.
PathoNostics’ assays will result in significantly faster diagnoses and specific species identification, leading to timely initiation of targeted therapy. Our proprietary technology platform uses real-time PCR and melting curve analysis to detect and differentiate pathogens and identify their resistance markers. Consequently, the avoidance of incorrect or unnecessary medical treatment, side effects, and costs will be achieved. We are convinced that the early diagnosis of fungal infections can greatly improve te clinical success and infection control.
Company’s Keywords:
molecular diagnostics of fungal infections, product development, medical devices
How Many Employees Does This Company Have?
6
Which Industry Does This Company Belong To?
medical devices
What Is the Annual Income?
What Is the Technology of All the Company’s Website?
Nginx
What Year Was the Company Founded?
2011
Rate us and Write a Review
